Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Outreach Crucial To Successful Drug Benefit, Kaiser Survey Shows

Executive Summary

Medicare beneficiary education and outreach efforts over the next 15 months will be crucial in assuring significant uptake of the Part D drug benefit, a Kaiser Family Foundation/Harvard School of Public Health survey indicates

You may also be interested in...



Schering Negotiating 150 Drug Contracts With Part D Plans

Schering-Plough will finish negotiations on more than 150 contracts with prospective Medicare prescription drug plans (PDPs) over the summer

Schering Negotiating 150 Drug Contracts With Part D Plans

Schering-Plough will finish negotiations on more than 150 contracts with prospective Medicare prescription drug plans (PDPs) over the summer

Medicare Discount Card Used For 3% Of Senior Rxs As Outreach Increases

The number of prescriptions filled using Medicare drug discount cards has reached 3% of all those filled by people age 65 and over, IMS Health VP-Industry Relations Doug Long said

Related Content

Topics

UsernamePublicRestriction

Register

PS044509

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel